Minute Media Bolsters Content Innovation With Strategic AI Acquisition

by THEFUTURE.TEAM

September 10, 2025

Strategic Expansion In Digital Sports Content

In a landmark deal underscoring its commitment to technological advancement, Minute Media—backed by BlackRock and Goldman Sachs—has acquired VideoVerse, a Mumbai-based AI startup renowned for its capabilities in extracting key highlights and generating dynamic sports content. VideoVerse, which has strong ties with industry giants such as the Indian Premier League, Women’s Premier League Cricket, FIFA+, Nippon TV, and Cubber TV, brings cutting-edge technology to Minute Media’s already expansive portfolio that includes iconic brands like Sports Illustrated and The Players’ Tribune.

Leveraging Advanced AI for Enhanced User Engagement

Founded in 2016 by Vinayak Srivastav, Saket Dandotia, and Alok Patil, VideoVerse initially developed AI tools for diverse applications, ranging from content moderation for film certifications to e-commerce object identification. Over time, the company strategically pivoted towards perfecting its video editing and detection tools specifically for sports broadcasting. This evolution has seen VideoVerse herald technological breakthroughs, including automated highlight generation and AI-powered translations, enabling broadcasters to curate tailored content packages that resonate with a global audience.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Robust Financials and a Promising Future

Although specific valuation details were not disclosed, sources indicate that VideoVerse was valued between $200 million and $250 million at its last funding round in 2023. With a track record of generating $65 million in revenue and maintaining a healthy EBITDA margin of 35% to 40%, the acquisition represents a significant milestone for Minute Media. CEO Asaf Peled highlighted that this is the largest acquisition by the company in terms of both value and scale, further strengthening its position in a competitive digital landscape.

Unlocking New Revenue Streams Through Innovation

Minute Media’s acquisition of VideoVerse is set to amplify its dual strengths in technology and content distribution. By integrating VideoVerse’s AI suite into its network of over 200 million monthly users and nearly 500 B2B publishers, Minute Media aims to pitch a compelling value proposition to U.S.-based sports leagues and beyond. This move is poised to generate substantial advertising revenue and enhance content monetization strategies by leveraging advanced AI capabilities to create and distribute richly engaging sports content.

An Industry Poised For Transformation

As digital consumption trends pivot towards mobile-first, dynamic content experiences, Minute Media’s strategic investment in VideoVerse underscores a broader industry shift. Fans increasingly demand content that transcends traditional coverage, and this acquisition is a calculated effort to meet that demand. With its eyes set on expanding its footprint in international markets, Minute Media is well-positioned to lead the charge in the next generation of digital sports media.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Breaking news